1616000: Bard PowerPort ClearVue Slim, 6F ChronoFlex Catheter, Silicone Filled, Intermediate

Sign in to add this product to your favorites!
Price: | $279.00 EACH |
---|---|
Quantity: | |
In Stock: | 1 eaches |
Expiration: | 02-2026 |
Related Items
CT60LTBANFVI - Size: 6.0F $249.00 EACH AngioDynamics Smart Port Low Profile Port w/Vortex & Endexo, Titanium Port w/Non-Filled Suture Holes and 6F Attached BioFlo Catheter (No Box) Exp: 11-2025 Units in stock: 3 | Order Qty |
CT60LPBDVI - Size: 6.0F $202.50 per box of 1 AngioDynamics Smart Port Plastic Low Profile Port w/Vortex & Endexo, Filled Suture Holes and 6F Detached BioFlo Catheter Exp: 07-2026 Units in stock: 1 box of 1 | Order Qty |
0605850-SD - Size: 6.0F $70.99 EACH Bard X-Port Ti Low-Profile Implantable Port with 6F Attachable Open-Ended Polyurethane, Intermediate Exp: 09-2025 Units in stock: 1 | Order Qty |
1716000 - Size: 6.0F $249.00 EACH Bard PowerPort Slim Ti Implantable Port 6F, Intermediate Exp: 04-2026 Units in stock: 1 | Order Qty |
0605550 - Size: 6.0F $189.00 EACH Bard SlimPort Ti Implantable Port, 6F Exp: 07-2026 Units in stock: 1 | Order Qty |
0605510 - Size: 6.0F $175.50 EACH BardPort Ti Low-Profile Implantable Port with 6F Open-Ended Single-Lumen Venous Catheter Exp: 08-2026 (or later) Units in stock: 3 | Order Qty |
1716071 - Size: 6.0F $364.00 EACH Bard PowerPort Slim Ti Implantable Port 6F, Microintroducer Exp: 12-2025 Units in stock: 1 | Order Qty |
Additional Details
BD Bard PowerPort ClearVue Slim
Silicone Filled / Intermediate
- Suture: Silicone Filled
- Kit Type: Intermediate
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.